TTK Healthcare Limited (IN:TTKHLTCARE)
:TTKHLTCARE
Want to see IN:TTKHLTCARE full AI Analyst Report?
Top Page
TTK Healthcare Limited
(TTKHLTCARE)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹971.00
▼(-5.64% Downside)
Action:DowngradedDate:03/21/26
The score is primarily supported by strong financial performance (revenue growth and a stable, low-debt balance sheet), but it is meaningfully reduced by weak cash flow quality and a bearish technical trend. Valuation is only moderate due to a high P/E with a modest dividend yield.
Positive Factors
Low leverage / strong balance sheet
Low leverage and a strong equity ratio provide durable financial stability, lowering default risk and preserving flexibility to fund capex, working capital, or strategic M&A. High ROE implies efficient capital use, supporting sustainable profit generation across cycles.
Negative Factors
Negative operating and free cash flow
Persistent negative operating and free cash flow undermines internal funding for capex, working capital, and dividends. Over months this forces reliance on external financing or equity, raising costs and constraining strategic investments despite reported profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
Low leverage and a strong equity ratio provide durable financial stability, lowering default risk and preserving flexibility to fund capex, working capital, or strategic M&A. High ROE implies efficient capital use, supporting sustainable profit generation across cycles.
Read all positive factors
TTK Healthcare Limited (TTKHLTCARE) vs. iShares MSCI India ETF (INDA)
Market Cap
₹12.82B
Dividend Yield0.95%
Average Volume (3M)82.00
Price to Earnings (P/E)34.8
Beta (1Y)0.82
Revenue Growth4.73%
EPS Growth-28.30%
CountryIN
Employees1,316
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - General
Share Statistics
EPS (TTM)46.90
Shares Outstanding14,130,333
10 Day Avg. Volume50
30 Day Avg. Volume82
Financial Highlights & Ratios
PEG Ratio0.68
Price to Book (P/B)1.57
Price to Sales (P/S)1.91
P/FCF Ratio-99.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TTK Healthcare Limited Business Overview & Revenue Model
Company Description
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulati...
How the Company Makes Money
TTK Healthcare makes money primarily by manufacturing and selling healthcare and consumer health products. Revenue is generated from (1) sales of pharmaceutical formulations and related healthcare products to trade channels (e.g., distributors, ph...
TTK Healthcare Limited Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
85
Very Positive
Cash Flow
65
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.25B | 8.73B | 7.48B | 7.25B | 5.99B | 4.76B |
| Gross Profit | 5.48B | 5.04B | 4.07B | 3.77B | 3.09B | 1.38B |
| EBITDA | 1.01B | 1.06B | 999.35M | 796.81M | 406.58M | 373.52M |
| Net Income | 662.66M | 816.57M | 628.42M | 6.40B | 415.88M | 464.41M |
Balance Sheet | ||||||
| Total Assets | 12.96B | 12.81B | 12.01B | 11.70B | 5.59B | 4.94B |
| Cash, Cash Equivalents and Short-Term Investments | 6.01B | 8.55B | 8.45B | 8.47B | 2.73B | 2.27B |
| Total Debt | 285.86M | 242.19M | 228.11M | 273.29M | 222.13M | 191.44M |
| Total Liabilities | 2.10B | 2.16B | 2.00B | 2.17B | 2.29B | 2.00B |
| Stockholders Equity | 10.85B | 10.65B | 10.01B | 9.53B | 3.30B | 2.95B |
Cash Flow | ||||||
| Free Cash Flow | -254.40M | -168.16M | -153.27M | -377.75M | 385.02M | 946.88M |
| Operating Cash Flow | -225.48M | -39.76M | -49.43M | -260.76M | 449.96M | 964.21M |
| Investing Cash Flow | 397.52M | 201.03M | 284.94M | 329.59M | -305.47M | -772.39M |
| Financing Cash Flow | -135.11M | -180.81M | -219.11M | -124.26M | -51.77M | -171.56M |
TTK Healthcare Limited Technical Analysis
Negative
1029.00
Price Trends
877.46
Negative
959.96
Negative
1079.62
Negative
Market Momentum
1.42
Negative
54.72
Neutral
80.72
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TTKHLTCARE, the sentiment is Negative. The current price of 1029 is above the 20-day moving average (MA) of 824.06, above the 50-day MA of 877.46, and below the 200-day MA of 1079.62, indicating a neutral trend. The MACD of 1.42 indicates Negative momentum. The RSI at 54.72 is Neutral, neither overbought nor oversold. The STOCH value of 80.72 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:TTKHLTCARE.
TTK Healthcare Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₹18.05B | 27.93 | ― | 0.71% | 19.20% | 7.47% | |
70 Outperform | ₹37.89B | 29.96 | ― | 0.13% | 14.96% | 27.42% | |
67 Neutral | ₹20.43B | 38.21 | ― | 0.16% | 16.77% | 21.24% | |
64 Neutral | ₹12.82B | 34.84 | ― | 0.95% | 4.73% | -28.30% | |
63 Neutral | ₹16.67B | 24.83 | ― | 0.68% | 10.09% | 15.35% | |
53 Neutral | ₹10.17B | 20.91 | ― | 0.24% | 17.32% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:TTKHLTCARE
TTK Healthcare Limited
928.60
-297.22
-24.25%
IN:AMRUTANJAN
Amrutanjan Health Care Limited
577.00
-113.60
-16.45%
IN:BAJAJHCARE
Bajaj Healthcare Ltd
328.25
-191.73
-36.87%
IN:SMSPHARMA
SMS Pharmaceuticals Limited
405.35
160.59
65.61%
IN:VIMTALABS
Vimta Labs Limited
476.70
-36.65
-7.14%
IN:WINDLAS
Windlas Biotech Ltd.
858.10
-115.30
-11.85%
TTK Healthcare Limited Corporate Events
TTK Healthcare Shareholder Declares Nil Holding Under SEBI Takeover Rules
Apr 10, 2026
TTK Healthcare Limited disclosed that shareholder Stina Ostlund Vasu has filed a declaration under Regulation 31(4) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. She confirmed her shareholding in the company is nil...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.